Nausea and vomiting in advanced cancer

Area of Science:

• Oncology
• Pharmacology
• Palliative Care

Background:

• Nausea and vomiting are distinct but often co-occurring symptoms in advanced cancer patients.
• Current management guidelines often recommend an etiology-based approach to anti-emetic selection.
• The choice of anti-emetic depends on identifying the triggered emetogenic pathway and blocking key receptors.

Purpose of the Study:

• To review the management of nausea and vomiting in advanced cancer.
• To compare the efficacy of etiology-based versus empirical approaches to anti-emetic therapy.
• To highlight the need for standardized assessment tools for future research.

Main Methods:

• Literature search of The Cochrane Library (2010) and Ovid MEDLINE (1966-2010).
• Review of current guidelines and proposed management strategies for nausea and vomiting.
• Analysis of available evidence on anti-emetic efficacy.

Main Results:

• Both etiology-based and empirical approaches to managing nausea and vomiting may have similar overall efficacy.
• Limited evidence exists directly comparing the two approaches.
• No published studies directly compare the empirical and etiology-based strategies.

Conclusions:

• Further research using standardized assessment and outcome tools is necessary.
• Well-designed studies are needed to establish the efficacy of conventional and newer anti-emetic agents.
• Separate assessment of nausea and vomiting is crucial for effective patient management.